PMID- 23070023 OWN - NLM STAT- MEDLINE DCOM- 20130910 LR - 20231213 IS - 1432-2072 (Electronic) IS - 0033-3158 (Print) IS - 0033-3158 (Linking) VI - 226 IP - 2 DP - 2013 Mar TI - Discriminative stimulus effects of N,N-diisopropyltryptamine. PG - 241-6 LID - 10.1007/s00213-012-2891-x [doi] AB - RATIONALE: Serotonergic hallucinogens such as (+)-lysergic acid diethylamide (LSD) and dimethyltryptamine (DMT) produce distinctive visual effects, whereas the synthetic hallucinogen N,N-diisopropyltryptamine (DiPT) is known for its production of auditory distortions. OBJECTIVE: This study compares the discriminative stimulus effects of DiPT to those of visual hallucinogens. METHODS: Adult male rats were trained to discriminate DiPT (5 mg/kg, 15 min) from saline under a FR10 schedule. A dose-effect and time course of DiPT's discriminative stimulus effects were established. DMT, (-)-2,5-dimethoxy-4-methylamphetamine (DOM), LSD, (+/-)-methylenedioxymethamphetamine (MDMA), and (+)-methamphetamine were tested for cross-substitution in DiPT-trained animals. RESULTS: Rats learned to discriminate DiPT from saline in an average of 60 training sessions (30 drug and 30 saline). DiPT (0.5-5 mg/kg) produced dose-dependent increases in drug-appropriate responding (DAR) to 99 % (ED(50) = 2.47 mg/kg). Onset of the discriminative stimulus effects was within 5 min, and the effects dissipated within 4 h. Full substitution for the discriminative stimulus effects of DiPT occurred with LSD, DOM, and MDMA. DMT only partially substituted for DiPT (65 % DAR), whereas (+)-methamphetamine failed to substitute for DiPT (29 % DAR). CONCLUSIONS: The discriminative stimulus effects of DiPT were similar those of a number of synthetic hallucinogens, only partially similar to those of DMT, but not similar to (+)-methamphetamine. The putative DiPT-induced auditory distortions do not lead to discriminative stimulus effects distinguishable from other hallucinogens. FAU - Carbonaro, Theresa M AU - Carbonaro TM AD - Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, 3500 Camp Bowie Blvd, Fort Worth, TX 76107-2699, USA. FAU - Forster, Michael J AU - Forster MJ FAU - Gatch, Michael B AU - Gatch MB LA - eng GR - HHSN271200700014C/DA/NIDA NIH HHS/United States GR - T32 AG020494/AG/NIA NIH HHS/United States GR - N01 DA78872/DA/NIDA NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20121016 PL - Germany TA - Psychopharmacology (Berl) JT - Psychopharmacology JID - 7608025 RN - 0 (Hallucinogens) RN - 0 (Tryptamines) RN - 14780-24-6 (N,N-diisopropyltryptamine) RN - 15588-95-1 (DOM 2,5-Dimethoxy-4-Methylamphetamine) RN - 44RAL3456C (Methamphetamine) RN - 8NA5SWF92O (Lysergic Acid Diethylamide) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) SB - IM MH - DOM 2,5-Dimethoxy-4-Methylamphetamine/pharmacology MH - Animals MH - Discrimination Learning/*drug effects MH - Dose-Response Relationship, Drug MH - Hallucinogens/*pharmacology MH - Lysergic Acid Diethylamide/pharmacology MH - Male MH - Methamphetamine/pharmacology MH - N-Methyl-3,4-methylenedioxyamphetamine/pharmacology MH - Rats MH - Rats, Sprague-Dawley MH - Tryptamines/*pharmacology PMC - PMC3577941 MID - NIHMS415148 EDAT- 2012/10/17 06:00 MHDA- 2013/09/11 06:00 PMCR- 2014/03/01 CRDT- 2012/10/17 06:00 PHST- 2012/08/08 00:00 [received] PHST- 2012/10/03 00:00 [accepted] PHST- 2012/10/17 06:00 [entrez] PHST- 2012/10/17 06:00 [pubmed] PHST- 2013/09/11 06:00 [medline] PHST- 2014/03/01 00:00 [pmc-release] AID - 10.1007/s00213-012-2891-x [doi] PST - ppublish SO - Psychopharmacology (Berl). 2013 Mar;226(2):241-6. doi: 10.1007/s00213-012-2891-x. Epub 2012 Oct 16.